Insulin receptor substrates are essential for the bioenergetic and hypertrophic response of the heart to exercise training

Molecular and Cellular Biology

Volumn 34, Issue 18, 2014, Pages 3450-3460

  Riehle, Christian ^a,b   Wende, Adam R ^b,c   Zhu, Yi ^b,e   Oliveira, Karen J ^b   Pereira, Renata O ^a,b   Jaishy, Bharat P ^a,b   Bevins, Jack ^b   Valdez, Steven ^b   Noh, Junghyun ^b   Kim, Bum Jun ^b   Moreira, Annie Bello ^b   Weatherford, Eric T ^a   Manivel, Rajkumar ^a   Rawlings, Tenley A ^b   Rech, Monika ^b   White, Morris F ^d   Abel, E Dale ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c University of Alabama at Birmingham   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOENERGY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; EXERCISE; FATTY ACID OXIDATION; FEMALE; FORCED SWIM TEST; GLYCOGEN SYNTHESIS; HEART DEVELOPMENT; HEART MITOCHONDRION; HEART SIZE; HEART VENTRICLE HYPERTROPHY; METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEPHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GLYCOGEN; HEART; INSULIN RECEPTOR SUBSTRATE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOCHONDRIA; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN ISOFORMS; SIGNAL TRANSDUCTION; SWIMMING; TRANSCRIPTION FACTORS;

EID: 84906061866     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00426-14     Document Type: Article

References (38)

1. Abel ED, Doenst T. 2011. Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy. Cardiovasc. Res. 90:234-242. http://dx.doi.org/10.1093/cvr/cvr015.
2. DornGW,II. 2007. The fuzzy logic of physiological cardiac hypertrophy. Hypertension 49:962-970. http://dx.doi.org/10.1161/HYPERTENSIONAHA.106.079426.
3. Shiojima I, Walsh K. 2006. Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. Genes Dev. 20:3347-3365. http://dx.doi.org/10.1101/gad.1492806.
4. Belke DD, Betuing S, Tuttle MJ, Graveleau C, Young ME, Pham M, Zhang D, Cooksey RC, McClain DA, Litwin SE, Taegtmeyer H, Severson D, Kahn CR, Abel ED. 2002. Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J. Clin. Invest. 109:629-639. http://dx.doi.org/10.1172/JCI13946.
5. Kim J, Wende AR, Sena S, Theobald HA, Soto J, Sloan C, Wayment BE, Litwin SE, Holzenberger M, LeRoith D, Abel ED. 2008. Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy. Mol. Endocrinol. 22:2531-2543. http://dx.doi.org/10.1210/me.2008-0265.
6. Boudina S, Bugger H, Sena S, O'Neill BT, Zaha VG, Ilkun O, Wright JJ, Mazumder PK, Palfreyman E, Tidwell TJ, Theobald H, Khalimonchuk O, Wayment B, Sheng X, Rodnick KJ, Centini R, Chen D, Litwin SE, Weimer BE, Abel ED. 2009. Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart. Circulation 119:1272-1283. http://dx.doi.org/10.1161/CIRCULATIONAHA.108.792101.
7. Neri Serneri GG, Boddi M, Modesti PA, Cecioni I, Coppo M, Padeletti L, Michelucci A, Colella A, Galanti G. 2001. Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes. Circ. Res. 89:977-982. http://dx.doi.org/10.1161/hh2301.100982.
8. Scheinowitz M, Kessler-Icekson G, Freimann S, Zimmermann R, Schaper W, Golomb E, Savion N, Eldar M. 2003. Short- and long-term swimming exercise training increases myocardial insulin-like growth factor- I gene expression. Growth Horm. IGF Res. 13:19-25. http://dx.doi.org/10.1016/S1096-6374(02)00137-5.
9. DeBosch B, Treskov I, Lupu TS, Weinheimer C, Kovacs A, Courtois M, Muslin AJ. 2006. Akt1 is required for physiological cardiac growth. Circulation 113:2097-2104. http://dx.doi.org/10.1161/CIRCULATIONAHA.105.595231.
10. McMullen JR, Shioi T, Zhang L, Tarnavski O, Sherwood MC, Kang PM, Izumo S. 2003. Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 100:12355-12360. http://dx.doi.org/10.1073/pnas.1934654100.
11. McMullen JR, Shioi T, Huang WY, Zhang L, Tarnavski O, Bisping E, Schinke M, Kong S, Sherwood MC, Brown J, Riggi L, Kang PM, Izumo S. 2004. The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110alpha) pathway. J. Biol. Chem. 279:4782-4793. http://dx.doi.org/10.1074/jbc.M310405200.
12. O'Neill BT, Kim J, Wende AR, Theobald HA, Tuinei J, Buchanan J, Guo A, Zaha VG, Davis DK, Schell JC, Boudina S, Wayment B, Litwin SE, Shioi T, Izumo S, Birnbaum MJ, Abel ED. 2007. A conserved role for phosphatidylinositol 3-kinase but not Akt signaling in mitochondrial adaptations that accompany physiological cardiac hypertrophy. Cell Metab. 6:294-306. http://dx.doi.org/10.1016/j.cmet.2007.09.001.
13. Araki E, Lipes MA, Patti ME, Bruning JC, Haag B, III, Johnson RS, Kahn CR. 1994. Alternative pathway of insulin signalling in mice withtargeted disruption of the IRS-1 gene. Nature 372:186-190. http://dx.doi.org/10.1038/372186a0.
14. Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T, Terauchi Y, Ueki K, Kaburagi Y, Satoh S, Sekihara H, Yoshioka S, Horikoshi H, Furuta Y, Ikawa Y, Kasuga M, Yazaki Y, Aizawa S. 1994. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372:182-186. http://dx.doi.org/10.1038/372182a0.
15. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF. 1998. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900-904. http://dx.doi.org/10.1038/36116.
16. Abel ED, Kaulbach HC, Tian R, Hopkins JC, Duffy J, Doetschman T, Minnemann T, Boers ME, Hadro E, Oberste-Berghaus C, Quist W, Lowell BB, Ingwall JS, Kahn BB. 1999. Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart. J. Clin. Invest. 104:1703-1714. http://dx.doi.org/10.1172/JCI7605.
17. Dong XC, Copps KD, Guo S, Li Y, Kollipara R, DePinho RA, White MF. 2008. Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation. Cell Metab. 8:65-76. http://dx.doi.org/10.1016/j.cmet.2008.06.006.
18. Lin X, Taguchi A, Park S, Kushner JA, Li F, Li Y, White MF. 2004. Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. J. Clin. Invest. 114:908-916. http://dx.doi.org/10.1172/JCI22217.
19. Riehle C, Wende AR, Zaha VG, Pires KM, Wayment B, Olsen C, Bugger H, Buchanan J, Wang X, Moreira AB, Doenst T, Medina-Gomez G, Litwin SE, Lelliott CJ, Vidal-Puig A, Abel ED. 2011. PGC-1beta deficiency accelerates the transition to heart failure in pressure overload hypertrophy. Circ. Res. 109:783-793. http://dx.doi.org/10.1161/CIRCRESAHA.111.243964.
20. Sena S, Rasmussen IR, Wende AR, McQueen AP, Theobald HA, Wilde N, Pereira RO, Litwin SE, Berger JP, Abel ED. 2007. Cardiac hypertrophy caused by peroxisome proliferator-activated receptor-gamma agonist treatment occurs independently of changes in myocardial insulin signaling. Endocrinology 148:6047-6053. http://dx.doi.org/10.1210/en.2006-1559.
21. Riehle C, Wende AR, Sena S, Pires KM, Pereira RO, Zhu Y, Bugger H, Frank D, Bevins J, Chen D, Perry CN, Dong XC, Valdez S, Rech Sheng MX, Weimer BC, Gottlieb RA, White MF, Abel ED. 2013. Insulin receptor substrate signaling suppresses neonatal autophagy in the heart. J. Clin. Invest. 123:5319-5333. http://dx.doi.org/10.1172/JCI71171.
22. Haemmerle G, Moustafa T, Woelkart G, Buttner S, Schmidt A, van de Weijer T, Hesselink M, Jaeger D, Kienesberger PC, Zierler K, Schreiber R, Eichmann T, Kolb D, Kotzbeck P, Schweiger M, Kumari M, Eder S, Schoiswohl G, Wongsiriroj N, Pollak NM, Radner FP, Preiss-Landl K, Kolbe T, Rulicke T, Pieske B, Trauner M, Lass A, Zimmermann R, Hoefler G, Cinti S, Kershaw EE, Schrauwen P, Madeo F, Mayer B, Zechner R. 2011. ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-alpha and PGC-1. Nat. Med. 17:1076-1085. http://dx.doi.org/10.1038/nm.2439.
23. Wende AR, Schaeffer PJ, Parker GJ, Zechner C, Han DH, Chen MM, Hancock CR, Lehman JJ, Huss JM, McClain DA, Holloszy JO, Kelly DP. 2007. A role for the transcriptional coactivator PGC-1alpha in muscle refueling. J. Biol. Chem. 282:36642-36651. http://dx.doi.org/10.1074/jbc.M707006200.
24. Hardt SE, Sadoshima J. 2002. Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development. Circ. Res. 90:1055-1063. http://dx.doi.org/10.1161/01.RES.0000018952.70505.F1.
25. Gingras AC, Gygi SP, Raught B, Polakiewicz RD, Abraham RT, Hoekstra MF, Aebersold R, Sonenberg N. 1999. Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev. 13:1422-1437. http://dx.doi.org/10.1101/gad.13.11.1422.
26. Chen J, Parsons S, Brautigan DL. 1994. Tyrosine phosphorylation of protein phosphatase 2A in response to growth stimulation and v-src transformation of fibroblasts. J. Biol. Chem. 269:7957-7962.
27. Chen J, Martin BL, Brautigan DL. 1992. Regulation of protein serinethreonine phosphatase type-2A by tyrosine phosphorylation. Science 257: 1261-1264. http://dx.doi.org/10.1126/science.1325671.
28. Ugi S, Imamura T, Maegawa H, Egawa K, Yoshizaki T, Shi K, Obata T, Ebina Y, Kashiwagi A, Olefsky JM. 2004. Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes. Mol. Cell. Biol. 24:8778-8789. http://dx.doi.org/10.1128/MCB.24.19.8778-8789.2004.
29. Yokoyama N, Reich NC, Miller WT. 2003. Determinants for the inter-action between Janus kinase 2 and protein phosphatase 2A. Arch. Biochem. Biophys. 417:87-95. http://dx.doi.org/10.1016/S0003-9861(03)00333-3.
30. Argetsinger LS, Kouadio JL, Steen H, Stensballe A, Jensen ON, Carter-Su C. 2004. Autophosphorylation of JAK2 on tyrosines 221 and 570 regulates its activity. Mol. Cell. Biol. 24:4955-4967. http://dx.doi.org/10.1128/MCB.24.11.4955-4967.2004.
31. Simon AR, Vikis HG, Stewart S, Fanburg BL, Cochran BH, Guan KL. 2000. Regulation of STAT3 by direct binding to the Rac1 GTPase. Science 290:144-147. http://dx.doi.org/10.1126/science.290.5489.144.
32. Burelle Y, Wambolt RB, Grist M, Parsons HL, Chow JC, Antler C, Bonen A, Keller A, Dunaway GA, Popov KM, Hochachka PW, Allard MF. 2004. Regular exercise is associated with a protective metabolic phenotype in the rat heart. Am. J. Physiol. Heart Circ. Physiol. 287:H1055-H1063. http://dx.doi.org/10.1152/ajpheart.00925.2003.
33. Luo J, McMullen JR, Sobkiw CL, Zhang L, Dorfman AL, Sherwood MC, Logsdon MN, Horner JW, DePinho RA, Izumo S, Cantley LC. 2005. Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy. Mol. Cell. Biol. 25:9491-9502. http://dx.doi.org/10.1128/MCB.25.21.9491-9502.2005.
34. Shioi T, Kang PM, Douglas PS, Hampe J, Yballe CM, Lawitts J, Cantley LC, Izumo S. 2000. The conserved phosphoinositide 3-kinase pathwaydetermines heart size in mice. EMBO J. 19:2537-2548. http://dx.doi.org/10.1093/emboj/19.11.2537.
35. Ikeda H, Shiojima I, Ozasa Y, Yoshida M, Holzenberger M, Kahn CR, Walsh K, Igarashi T, Abel ED, Komuro I. 2009. Interaction of myocardial insulin receptor and IGF receptor signaling in exercise-induced cardiac hypertrophy. J. Mol. Cell. Cardiol. 47:664-675. http://dx.doi.org/10.1016/j.yjmcc.2009.08.028.
36. Chan AY, Soltys CL, Young ME, Proud CG, Dyck JR. 2004. Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte. J. Biol. Chem. 279:32771-32779. http://dx.doi.org/10.1074/jbc.M403528200.
37. Mauvais-Jarvis F, Ueki K, Fruman DA, Hirshman MF, Sakamoto K, Goodyear LJ, Iannacone M, Accili D, Cantley LC, Kahn CR. 2002. Reduced expression of the murine p85alpha subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes. J. Clin. Invest. 109:141-149. http://dx.doi.org/10.1172/JCI13305.
38. Leone TC, Lehman JJ, Finck BN, Schaeffer PJ, Wende AR, Boudina S, Courtois M, Wozniak DF, Sambandam N, Bernal-Mizrachi C, Chen Z, Holloszy JO, Medeiros DM, Schmidt RE, Saffitz JE, Abel ED, Semenkovich CF, Kelly DP. 2005. PGC-1alpha deficiency causes multisystem energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol. 3:e101. http://dx.doi.org/10.1371/journal.pbio.0030101.